These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29688760)

  • 1. Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical Trial.
    Sagel SD; Khan U; Jain R; Graff G; Daines CL; Dunitz JM; Borowitz D; Orenstein DM; Abdulhamid I; Noe J; Clancy JP; Slovis B; Rock MJ; McCoy KS; Strausbaugh S; Livingston FR; Papas KA; Shaffer ML
    Am J Respir Crit Care Med; 2018 Sep; 198(5):639-647. PubMed ID: 29688760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant supplementation for lung disease in cystic fibrosis.
    Ciofu O; Lykkesfeldt J
    Cochrane Database Syst Rev; 2014 Aug; (8):CD007020. PubMed ID: 25102015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant supplementation for lung disease in cystic fibrosis.
    Ciofu O; Smith S; Lykkesfeldt J
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD007020. PubMed ID: 31580490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis.
    Papas KA; Sontag MK; Pardee C; Sokol RJ; Sagel SD; Accurso FJ; Wagener JS
    J Cyst Fibros; 2008 Jan; 7(1):60-7. PubMed ID: 17569601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial.
    Conrad C; Lymp J; Thompson V; Dunn C; Davies Z; Chatfield B; Nichols D; Clancy J; Vender R; Egan ME; Quittell L; Michelson P; Antony V; Spahr J; Rubenstein RC; Moss RB; Herzenberg LA; Goss CH; Tirouvanziam R
    J Cyst Fibros; 2015 Mar; 14(2):219-27. PubMed ID: 25228446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D for the Immune System in Cystic Fibrosis (DISC): a double-blind, multicenter, randomized, placebo-controlled clinical trial.
    Tangpricha V; Lukemire J; Chen Y; Binongo JNG; Judd SE; Michalski ES; Lee MJ; Walker S; Ziegler TR; Tirouvanziam R; Zughaier SM; Chesdachai S; Hermes WA; Chmiel JF; Grossmann RE; Gaggar A; Joseph PM; Alvarez JA
    Am J Clin Nutr; 2019 Mar; 109(3):544-553. PubMed ID: 30793177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial.
    Griese M; Kappler M; Eismann C; Ballmann M; Junge S; Rietschel E; van Koningsbruggen-Rietschel S; Staab D; Rolinck-Werninghaus C; Mellies U; Köhnlein T; Wagner T; König S; Teschler H; Heuer HE; Kopp M; Heyder S; Hammermann J; Küster P; Honer M; Mansmann U; Beck-Speier I; Hartl D; Fuchs C; ; Hector A
    Am J Respir Crit Care Med; 2013 Jul; 188(1):83-9. PubMed ID: 23631796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant micronutrients for lung disease in cystic fibrosis.
    Shamseer L; Adams D; Brown N; Johnson JA; Vohra S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD007020. PubMed ID: 21154377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.
    Evans JR; Lawrenson JG
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD000253. PubMed ID: 28756617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
    Evans JR; Lawrenson JG
    Cochrane Database Syst Rev; 2023 Sep; 9(9):CD000254. PubMed ID: 37702300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function.
    Wood LG; Fitzgerald DA; Lee AK; Garg ML
    Am J Clin Nutr; 2003 Jan; 77(1):150-9. PubMed ID: 12499335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flaxseed modulates inflammatory and oxidative stress biomarkers in cystic fibrosis: a pilot study.
    Turowski JB; Pietrofesa RA; Lawson JA; Christofidou-Solomidou M; Hadjiliadis D
    BMC Complement Altern Med; 2015 May; 15():148. PubMed ID: 25963404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant Micronutrients and Essential Fatty Acids Supplementation on Cystic Fibrosis Outcomes: A Systematic Review.
    Simon MISDS; Dalle Molle R; Silva FM; Rodrigues TW; Feldmann M; Forte GC; Marostica PJC
    J Acad Nutr Diet; 2020 Jun; 120(6):1016-1033.e1. PubMed ID: 32249071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
    Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
    Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
    Skilton M; Krishan A; Patel S; Sinha IP; Southern KW
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009841. PubMed ID: 30616300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial.
    Mayer-Hamblett N; Retsch-Bogart G; Kloster M; Accurso F; Rosenfeld M; Albers G; Black P; Brown P; Cairns A; Davis SD; Graff GR; Kerby GS; Orenstein D; Buckingham R; Ramsey BW;
    Am J Respir Crit Care Med; 2018 Nov; 198(9):1177-1187. PubMed ID: 29890086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an antioxidant-rich multivitamin supplement in cystic fibrosis.
    Sagel SD; Sontag MK; Anthony MM; Emmett P; Papas KA
    J Cyst Fibros; 2011 Jan; 10(1):31-6. PubMed ID: 20961818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients.
    Wood LG; Fitzgerald DA; Gibson PG; Cooper DM; Garg ML
    Am J Clin Nutr; 2002 Apr; 75(4):668-75. PubMed ID: 11916752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.